Table 7 IC₅₀ of the tested compounds against hepatocellular carcinoma cell line HePG2 and breast cancer cell line MCF-7

1

14.7

26.3

2

102

115

3

4.54

6.58

4

15.4

14.9

5

3.42

3.98

6

229

276

7

51.5

61.3

8

14.1

19.1

9

14.9

25.6

10

13.5

18.4

11a

243

249

11b

32.2

53.3

12

10.9

15.4

13

12.9

13.6

14

2.33

4.53

15

17.3

29

16

7.19

9.32

17

26.6

35.8

18

9.94

15.2

19

3.78

6.08

20

28.5

31.1

Doxorubicin

0.85

0.35